From: Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
Group | TC-1 group | U14/LV-HPV18 E6E7 group | U14/LV-HPV58 E6E7 group |
---|---|---|---|
AD-HPV16/18/58 mE6E7 vaccine group | 0.322 ± 0.18* | 0.344 ± 0.17 | 2.103 ± 1.220* |
AD-NC group | 0.902 ± 0.39 | 0.985 ± 0.57 | 5.862 ± 0.323 |
PBS group | 0.926 ± 0.50 | 0.940 ± 0.52 | 5.959 ± 1.059 |